BiomarkersHuman trial

The Addition of the AHA PREVENT Risk Model to NT-proBNP–Based Screening in Patients with Diabetes and Risk Factors for Heart Failure: An Exploratory Analysis of TARTAN-HF

ADA Scientific Sessions 2026 Abstract

The paper

TAYLOR-SWEET DR, PETRIE M, MCKINLEY G et al.

ADA Scientific Sessions 2026 Abstract · 5 Jun 2026

Presented at ADA Scientific Sessions 2026 · Late-breaking 2973-LB

doi.org/10.2337/db26-2973-lb